6th Meeting on External Quality Assessment in Molecular Pathology – Naples 2017

For the sixth consecutive year, representatives of the stakeholders involved in promoting accurate diagnostic testing in pathology for effective anti-cancer drug selection gathered in the second weekend of May 2017, in Naples, Italy. This very dynamic meeting always brings much discussion of the current key issues, and importantly, proposed solutions to optimising diagnostic testing quality read more…

IQN Path ASBL at the Naples 2016 Congress

The newly formed IQN Path ASBL joined the Naples 2016 Congress stakeholders involved in promoting accurate testing for anti-cancer drug selection. The conference was organised by the Italian Association of Medical Oncology (AIOM) with the European Society of Pathology (ESP) and the Italian Association of Surgical Pathology (SIAPEC-IAP), and with the endorsement of the European read more…

IQN Path invited to participate in a World Health Organisation (WHO) Technical Group meeting, September 21-22nd 2015

EQA is a important part of a wider framework for quality assurance of diagnostic testing. In many countries it is now of interest to establish EQA as national schemes and in those countries with well established EQA, to maintain and promote good practise in EQA. In order to assist in the establishment of national schemes read more…

4th QA meeting, Naples, Italy

Speakers from academia, industries, pharma, diagnostic companies, and national quality assurance organizers make presentations and exchange ideas and updates on the recent developments in quality assurance in Europe. The molecular working group of IQN Path meet at the annual Naples Meeting. Thanks to the participants and sponsors for a successful 4th meeting on External Quality read more…